S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Obama’s 2024 Confession (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Obama’s 2024 Confession (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Recession risks are fading, business economists say, but political tensions pose threat to economy
New Trump Bombshell (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Stock market today: World shares mostly higher after S&P 500 tops 5,000
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Obama’s 2024 Confession (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Obama’s 2024 Confession (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Recession risks are fading, business economists say, but political tensions pose threat to economy
New Trump Bombshell (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Stock market today: World shares mostly higher after S&P 500 tops 5,000
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Obama’s 2024 Confession (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Obama’s 2024 Confession (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Recession risks are fading, business economists say, but political tensions pose threat to economy
New Trump Bombshell (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Stock market today: World shares mostly higher after S&P 500 tops 5,000
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Obama’s 2024 Confession (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Obama’s 2024 Confession (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Recession risks are fading, business economists say, but political tensions pose threat to economy
New Trump Bombshell (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Stock market today: World shares mostly higher after S&P 500 tops 5,000

ArriVent BioPharma (AVBP) News Today

$21.01
-0.99 (-4.50%)
(As of 02/9/2024 08:55 PM ET)
SourceHeadline
marketbeat.com logoArriVent BioPharma (NASDAQ:AVBP) Stock Price Down 3.6%
marketbeat.com - February 9 at 3:02 PM
MarketBeat logoArriVent BioPharma, Inc. (NASDAQ:AVBP) Director Acquires $7,999,992.00 in Stock
americanbankingnews.com - February 3 at 4:18 AM
MarketBeat logoArriVent BioPharma, Inc. (NASDAQ:AVBP) Major Shareholder Acquires $9,999,990.00 in Stock
americanbankingnews.com - February 2 at 6:32 AM
Get ArriVent BioPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVBP and its competitors with MarketBeat's FREE daily newsletter.



AVBP Media Mentions By Week

AVBP Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AVBP
News Sentiment

1.23

0.92

Average
Medical
News Sentiment

AVBP News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AVBP Articles
This Week

2

4

AVBP Articles
Average Week

Get ArriVent BioPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVBP and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:AVBP) was last updated on 2/12/2024 by MarketBeat.com Staff

My Account -